IBSB: And then there were four

March 15, 2004

By hammersmith

A University of Arizona program that seeks to increase collaboration among life sciences faculty and improve technology commercialization efforts has pared its list of possible directors to four.

The Institute for Biomedical Science and Biotechnology announced its nationwide search in August and named a business development board in December to help define its long-term approach to economic development.

The short list includes UA plant sciences professor Vicki Chandler, who has served as the institute’s co-director since Thomas Baldwin, the institute’s founding director, retired from the position in July.

Other candidates include:

  • David T. Curiel, director of the Division of Human Gene Therapy and director of the Gene Therapy Center at The University of Alabama at Birmingham
  • John W. Kozarich, president and chief research and development officer of ActivX Biosciences in La Jolla, Calif.
  • Paul Rothman, Richard J. Stock Professor of Medicine and Microbiology at Columbia University.

IBSB will eventually be housed in a $65.7 million, 168,691-square-foot facility located near a new Medical Research building and the University Medical Center.

For more information:

UA institute has narrowed director candidates to four,” Arizona Daily Star, 03/04/2004